Amphastar Pharmaceuticals, Inc. (LSX:A11664) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Richard Prins Other companies: IGC Pharma, Inc. (Chairman · Since at least Mar 31, 2025) | Lead Independent Director · Since at least Aug 19, 2024 |
| Anthony T. Pierce | Director · Since at least Jul 9, 2026 |
| Bill Peters | Director · Since at least May 6, 2026 |
| David R. Gaugh | Director · Since at least Jul 18, 2025 |
| Diane G. Gerst | Director · Since at least Jun 1, 2026 |
| Floyd F Petersen | Director · Since at least Oct 4, 2017 |
| Gayle M. Deflin | Director · Since at least Jun 1, 2026 |
| Howard Lee | Director · Since at least Jun 3, 2026 |
| Jack Zhang | Chief Executive Officer, President, Chief Scientific Officer, and Director · Since at least Aug 6, 2026 |
| Jacob Liawatidewi | Director · Since at least May 27, 2026 |
| Marilyn J Purchase | Corp. Exec. VP of Operations · Jun 24, 2014 – Apr 9, 2015 · Past |
| Mary Luo | COO, Chief Scientist, Chairman, Director · Since at least Nov 13, 2017 |
| Michael A. Zasloff | Director · Since at least May 16, 2022 |
| Rong Zhou | SENIOR EVP, PRODUCTION CENTER · Since at least Dec 1, 2023 |